Abstract 18079: Targeted Use of Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure | Circulation
xmlinkhub
Understanding Freelite®, the lab test for serum free light chains
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Living With - HealthTree for Myeloma
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica